Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
161
datasets available to search
ShareScore release 0.9.0
Dataset results
161 results for “prospective validation”
CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation [ChIP-Seq cell lines]
GEO Series GSE284319. Homo sapiens. 35 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
Multi-institutional prospective validation of prognostic mRNA signatures in early stage squamous lung cancer (Alliance) [cohort I]
GEO Series GSE157009. Homo sapiens. 249 samples. Type: Expression profiling by array.
Multi-institutional prospective validation of prognostic mRNA signatures in early stage squamous lung cancer (Alliance) [Cohort II]
GEO Series GSE157010. Homo sapiens. 235 samples. Type: Expression profiling by array.
Multi-institutional prospective validation of prognostic mRNA signatures in early stage squamous lung cancer (Alliance)
GEO Series GSE157011. Homo sapiens. 484 samples. Type: Expression profiling by array.
CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation
GEO Series GSE284396. Homo sapiens. 90 samples. Type: Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing.
Development and Prospective Validation of a Heterogeneous Treatment Effect-Based Decision Model for Transarterial Chemoembolization Combined With or Without Atezolizumab Plus Bevacizumab in Unresectab
ClinicalTrials.gov study NCT07109336. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Prospective Validation Of The Eleveld TCI Model For Propofol In The Malaysian Obese Population
ClinicalTrials.gov study NCT05885100. IPD Sharing: NO. Countries: 0. Publications: 0.
Prospective Validation Study of an E-health Tool for Patient Selection for SCS
ClinicalTrials.gov study NCT06853795. IPD Sharing: NO. Countries: 0. Publications: 0.
Prospective Validation Study of a Uterine Fibroid-Related Infertility Prediction Model
ClinicalTrials.gov study NCT07177534. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Difficult Airways Scores Validation Difficult Laryngoscopy and Mask Ventilation: Prospective and Evaluative Study
ClinicalTrials.gov study NCT06511427. IPD Sharing: NO. Countries: 0. Publications: 0.
Prospective Study to Validate the Clinical Accuracy of Norbert Device to Measure Body Temperature
ClinicalTrials.gov study NCT05640310. IPD Sharing: NO. Countries: 0. Publications: 0.
Prospective Study to Validate the Clinical Accuracy of the Norbert Device to Measure Oxygen Saturation
ClinicalTrials.gov study NCT05685654. IPD Sharing: NO. Countries: 0. Publications: 0.
Prospective Trial of a Validated Algorithm for Warfarin Dosing
ClinicalTrials.gov study NCT02705976. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
A Prospective Validation Study of Radiomics in the Differential Diagnosis of Uterine Leiomyoma and Uterine Sarcoma
ClinicalTrials.gov study NCT07269535. IPD Sharing: NO. Countries: 0. Publications: 0.
Validation of Ocular Pain Questionnaire: Single-center, Prospective Observational Study
ClinicalTrials.gov study NCT06656260. IPD Sharing: Not stated. Countries: 0. Publications: 0.
AutoDx-DR Prospective Clinical Validation Study Protocol
ClinicalTrials.gov study NCT04627272. IPD Sharing: NO. Countries: 0. Publications: 0.
A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC
ClinicalTrials.gov study NCT06503042. IPD Sharing: NO. Countries: 0. Publications: 0.
RediScore: Prospective Validation of a pipeline for Homologous Recombination Deficiency Analysis
GEO Series GSE227800. Homo sapiens. 29 samples. Type: Expression profiling by SNP array.
Retrospective and prospective validation of a 33-gene signature to predict recurrence of lung cancer after surgery.
GEO Series GSE77803. Homo sapiens. 156 samples. Type: Expression profiling by array.
Dataset related to article "Prospective Validation of the ROL System in Substaging pT1 High-Grade Urothelial Carcinoma: Results from a Mono-Institutional Confirmatory Analysis in BCG Treated Patients"
<p>This record contains raw data related to article "Prospective Validation of the ROL System in Substaging pT1 High-Grade Urothelial Carcinoma: Results from a Mono-Institutional Confirmatory Analysis in BCG Treated Patients"</p><p><strong>Abstract</strong></p><p>Patients with pT1 high-grade (HG) urothelial carcinoma (UC) and a very high risk of progression might benefit from immediate radical cystectomy (RC), but this option remains controversial. Validation of a standardized method to evaluate the extent of lamina propria (LP) invasion (with recognized prognostic value) in transurethral resection (TURBT) specimens is still needed. The Rete Oncologica Lombarda (ROL) system showed a high predictive value for progression after TURBT in recent retrospective studies. The ROL system was supposed to be validated on a large prospective series of primary urothelial carcinomas from a single institution. From 2016 to 2020, we adopted ROL for all patients with pT1 HG UC on TURBT. We employed a 1.0-mm threshold to stratify tumors in ROL1 and ROL2. A total of 222 pT1 HG UC were analyzed. The median age was 74 years, with a predominance of men (73.8%). ROL was feasible in all cases: 91 cases were ROL1 (41%), and 131 were ROL2 (59%). At a median follow-up of 26.9 months (IQR 13.8-40.6), we registered 81 recurrences and 40 progressions. ROL was a significant predictor of tumor progression in both univariable (HR 3.53; CI 95% 1.56-7.99; <i>p</i> < 0.01) and multivariable (HR 2.88; CI 95% 1.24-6.66; <i>p</i> = 0.01) Cox regression analyses. At Kaplan-Meier estimates, ROL showed a correlation with both PFS (<i>p</i> = 0.0012) and RFS (<i>p</i> = 0.0167). Our results confirmed the strong predictive value of ROL for progression in a large prospective series. We encourage the application of ROL for reporting the extent of LP invasion, substaging T1 HG UC, and improving risk tables for urological decision-making.</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.